ASPE Original comments

ASPE Original Comments Feb 2014.docx

Next Series of Tobacco Use Supplements to the Current Population Survey (TUS-CPS) (NCI)

ASPE Original comments

OMB: 0925-0368

Document [docx]
Download: docx | pdf

ASPE Comments on the National Cancer Institute’s Tobacco Use Supplement to the Current Population Survey (TUS-CPS)



ASPE has reviewed this proposed collection of information and has the following comments on the Supporting Statement Part A and the Excel spreadsheet “Comparison of Key Features of Adult National Tobacco Surveys.”

Supporting Statement Part A: There are several references to the support for CDC’s National Adult Tobacco Survey (NATS) provided by FDA’s Center for Tobacco Products (CTP), stating that CTP has decided not to continue funding for the NATS after the 2013-2014 cycle. The supporting statement claims that, because of this, the survey is ending. Although the support from CTP will not continue, CDC has not confirmed that the NATS will not be fielded in future years, therefore, the supporting statement should be revised to omit this reference. (See attached Part A for changes on pages 5, 10, 12, and 14)

Excel Spreadsheet: The Comparison of Key Features of Adult National Tobacco Surveys table is particularly valuable for the review from OMB and complements the narrative from the supporting statement section on duplication; however, there are several issues that should be addressed or corrected:

Incorrect Links: several of the links are not functional addresses. These are either old sites or incorrect ones.

The Comparison document did not include the Health Information National Trends Survey (HINTS) on the list in Tab A Overview of Surveys, even though the original spreadsheet that was sent with the supporting statement and other material contained a sheet with the HINTS question by question comparison to the other major HHS surveys. We recommend that HINTS be included in Tab A, Overview of Surveys.

Please provide information on the following column headings, and describe the criteria that were used to categorize the surveys under each heading: Precision for non-oversampled subgroups; Policy and social norms. While the supporting statement has a good discussion of the information contained in Table 4, some additional detail would facilitate using the table for the survey comparisons.

For example, how was it determined that the NHIS, NHANES, and NSDUH surveys do not have precision for subgroups that weren’t oversampled under the heading “Precision for non-oversampled subgroups?” Oversampling in done in NHANES to increase the reliability and precision of estimates for the population subgroups that are of particular public health interest, but NHANES can be used to produce estimates of subgroups that weren’t oversampled. Researchers need to use the NHANES analytic guidelines to ensure that they take into account the proper use of the weights as well as the survey design, etc. Please explain why BRFSS is categorized as having precision for non-oversampled subgroups but NHIS, NHANES, and NSDUH do not have this precision according to the table.

Detailed Non-Cigarette Tobacco Product Use:

The spreadsheet indicates that NSDUH does not contain detailed questions on non-cigarette tobacco use; however, NSDUH actually does have detailed questions on some of these products. There is a set of questions on snuff, including on age first used, past 30 day use, frequency of use, brand names, brand used most often, etc. The same series of questions is also asked separately for chewing tobacco and cigars.

The spreadsheet also indicates that NHANES does not have detailed questions on non-cigarette tobacco use; however, NHANES has a set of questions on non-cigarette tobacco use, with separate questions on e-cigarettes, chewing tobacco, snuff, snus, and dissolvables. The focus in NHANES is on most recent use of these products as the questions are asked in the Mobile Examination Center (MEC) and will be analyzed in connection with the physical measures collected in the MEC. While not as detailed as the CPS TUS, it is important to acknowledge that these surveys do include such questions, since OMB has reviewed and approved their use and the table would suggest that such questions are only on the CPS TUS, NATS, and PATH.

State Level Estimates:

NSDUH is described as not able to produce state level estimates, however, NSDUH is specifically designed to produce state estimates as well as national estimates, and can also be used for estimates on a limited number of areas within states. The sample is sufficient to support small area estimates in each state and the District of Columbia while maintaining efficiency for national estimates. Information to make the state estimates is not available on the public use file and has restricted access, but SAMHSA publishes a report annually with prevalence estimates and 95% confidence intervals by state. See: http://www.samhsa.gov/data/NSDUH/2k12State/NSDUHsae2012/Index.aspx

Policy and Social Norms:

ASPE suggests that clarification is needed to the column with the heading “Policy and Social Norms,” as many of the surveys that are listed with “no” in this column have used “policy relevance” as a stated purpose for obtaining OMB approval. NSDUH is listed under this heading as not able to address policy issues and social norms. However, one of the purposes in the supporting statement for NSDUH is “to meet the needs of Federal policy makers and the substance abuse research, prevention, and treatment communities.” This is true for the NATS as well, and CDC justified their tobacco-related questions to OMB as “critical to FDA in monitoring the effectiveness and public perceptions of its regulatory activities.” (As stated earlier, although the CPS TUS supporting statement indicates that FDA is pulling support from NATS, CDC has not confirmed that the survey will be terminated and discontinued, therefore, the supporting statement should be revised to omit references to the discontinuation of NATS.) The NHIS has a stated purpose “for epidemiologic and policy analysis of time issues…” The information provided in this column contradicts the information that has been given to OMB to justify approval of these other information collection activities – one suggestion is to make this heading more specific, if possible. For example, NSDUH asks respondents about their perception of potential health risks related to smoking cigarettes, but does not have any questions in this area about other tobacco products, and there are no questions in the survey that ask about switching products. CPS TUS has questions on key policy areas that many of the other major surveys (except perhaps PATH and NATS) do not include are: flavored products, price, cessation, quit lines, etc. ASPE suggests that some clarity be provided in the headings to highlight key policy areas that are unique to CPS TUS.













If you have any questions, please contact Susan Queen (Susan.queen@hhs.gov) or Rachel Hornstein (Rachel.hornstein@hhs.gov)



File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorDHHS
File Modified0000-00-00
File Created2021-01-27

© 2024 OMB.report | Privacy Policy